Highlights from the 2019 ASCO Annual Meeting - Gastrointestinal Cancers

08/20/19 • 52 min

In this episode, we'll listen to Dr. Scott Berry, Dr. Marc Peeters and Dr. Sharlene Gill, discuss the important trials presented at ASCO 2019.

08:20 - Apact Trial

16:35 - Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA

24:15 - Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC

30:26 - ABC-06

35:35 - IDEA Study (High Risk Stage 2 Patients)

46:19 - Foxtrot Trial

08/20/19 • 52 min

Get a badge for your website that links back to this episode

Select type & size

Copy